Speeding tickets a good outcome even if it is an "I know nothing" & reiterating what's already known, that's really just highlighting the disparage in relation to peers. The value PAB currently sits at completely ignores all that is already known - $4M+ CaB / awaiting completion and data of MM Phase II, SC1 out-licensing on Phase II, multiple discovery & pre-clinical candidates all for a grand total current value of $12M. It stands 5-10x cheaper than many of it's peers and in a better position on many fronts.
FWIW if it can close at $0.031 or better today and at its highe the chart will be cracker.
patience, page-30
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $7.419K | 2.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 40557809 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 26688875 | 13 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |